HIV PRE-EXPOSURE PROPHYLAXIS
Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS trials appear
Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Monthly HIV prevention pill could replace daily dose
Prevention Recruiting nowThis phase 3 trial tests MK-8527, a once-monthly oral pill, to prevent HIV-1 infection in women. About 4580 HIV-negative women will take either MK-8527 monthly or a daily PrEP pill (Truvada) to see which works better and is safer. The goal is to offer a more convenient prevention…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention Recruiting nowThis large phase 3 trial is testing whether a new oral pill called MK-8527, taken just once a month, can prevent HIV infection as well as the standard daily PrEP pill. About 4,390 people at risk of HIV will be randomly assigned to receive either the monthly pill or daily Truvada …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
HIV counselors lead new push to offer prevention pills at family planning visits
Prevention Recruiting nowThis study tests a new way to offer HIV prevention pills (PrEP) to people visiting family planning clinics in Kenya. Instead of requiring a separate appointment, HIV counselors will provide PrEP screening and prescriptions right at the family planning visit. The goal is to see if…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
ERs could become frontline for HIV prevention: new study tests immediate PrEP
Prevention Recruiting nowThis study tests whether giving HIV prevention pills (PrEP) to people right in the emergency room helps them start and stay on prevention. Researchers will enroll 250 HIV-negative adults at risk for HIV in Dallas. Participants get a 30-day pill supply and a clinic appointment to …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New injectable HIV prevention program aims to protect latine communities
Prevention Recruiting nowThis study tests a long-acting injectable PrEP (lenacapavir) program designed specifically for Latine gay, bisexual men and transgender women. Researchers want to see if offering the shots at community organizations helps more people stay on HIV prevention compared to standard cl…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC